Role of nuclear receptors in lipid dysfunction and obesity-related diseases

Drug Metabolism and Disposition

Volumn 41, Issue 1, 2013, Pages 1-11

  Swanson, Hollie I ^a   Wada, Taira ^b   Xie, Wen ^b   Renga, Barbara ^c   Zampella, Angela ^d   Distrutti, Eleonora ^e   Fiorucci, Stefano ^c   Kong, Bo ^f   Thomas, Ann M ^g   Guo, Grace L ^f   Narayanan, Ramesh ^h   Yepuru, Muralimohan ^h   Dalton, James T ^h   Chiang, John Y L ⁱ  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^f RUTGERS UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h GTx Inc   (United States)

ⁱ Northeastern Ohio Medical University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; CELL NUCLEUS RECEPTOR; CELL PROTEIN; CONSTITUTIVE ANDROSTANE RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; FARNESOID X RECEPTOR; PREGNANE X RECEPTOR; PROTEIN TGR5; UNCLASSIFIED DRUG;

BILE ACID METABOLISM; CELL DIFFERENTIATION; CONFERENCE PAPER; DISORDERS OF LIPID METABOLISM; ENERGY EXPENDITURE; EXPERIMENTAL DIABETES MELLITUS; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LIPID DIET; LIPOGENESIS; METABOLIC DISORDER; MOLECULAR MODEL; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; WEIGHT GAIN; XENOBIOTIC METABOLISM;

BILE ACIDS AND SALTS; ENERGY METABOLISM; GLUCOSE; HUMANS; LIPIDS; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; XENOBIOTICS;

EID: 84871606255     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.048694     Document Type: Conference Paper

References (83)

1. Ai N, Krasowski MD, Welsh WJ, and Ekins S (2009) Understanding nuclear receptors using computational methods. Drug Discov Today 14:486-494.
2. Baggio LL and Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131-2157. (Pubitemid 46711096)
3. Borgius LJ, Steffensen KR, Gustafsson JA, and Treuter E (2002) Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP. J Biol Chem 277:49761-49766. (Pubitemid 36014422)
4. Brown M, Ning J, Ferreira JA, Bogener JL, and Lubahn DB (2009) Estrogen receptor-alpha and -beta and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. Am J Physiol Endocrinol Metab 296:E854-E861.
5. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk T, Grefhorst A, Bouchaert E, Fruchart JC, Gonzalez FJ, Kuipers F, and Staels B (2005) Transient impairment of the adaptive response to fasting in FXR-deficient mice. FEBS Lett 579:4076-4080. (Pubitemid 41021793)
6. Cariou B, van Harmelen K, and Duran-Sandoval D, et al. (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281:11039-11049. (Pubitemid 43855527)
7. Cheng J, Krausz KW, Tanaka N, and Gonzalez FJ (2012) Chronic exposure to rifaximin causes hepatic steatosis in pregnane x receptor-humanized mice. Toxicol Sci 129:456-468.
8. Chiang JY (2004) Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 40:539-551.
9. Cipriani S, Mencarelli A, Palladino G, and Fiorucci S (2010) FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res 51:771-784.
10. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, and Schaff HV (1997) Valvular heart disease associated with fenfluramine- phentermine. N Engl J Med 337:581-588. (Pubitemid 27360757)
11. Dong B, Saha PK, and Huang W, et al. (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA 106:18831-18836.
12. Downes M, Verdecia MA, and Roecker AJ, et al. (2003) A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11:1079-1092. (Pubitemid 36566328)
13. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, and Staels B (2005) The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 280:29971-29979. (Pubitemid 41177076)
14. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, and Staels B (2004) Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53:890-898. (Pubitemid 38436600)
15. Fang Y, Studer E, Mitchell C, Grant S, Pandak WM, Hylemon PB, and Dent P (2007) Conjugated bile acids regulate hepatocyte glycogen synthase activity in vitro and in vivo via Galphai signaling. Mol Pharmacol 71:1122-1128. (Pubitemid 46457015)
16. Fiorucci S and Baldelli F (2009) Farnesoid X receptor agonists in biliary tract disease. Curr Opin Gastroenterol 25:252-259.
17. Fiorucci S, Mencarelli A, Palladino G, and Cipriani S (2009) Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 30:570-580.
18. Foryst-Ludwig A, Clemenz M, and Hohmann S, et al. (2008) Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 4:e1000108.
19. Foryst-Ludwig A and Kintscher U (2010) Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122:74-81.
20. Gao J, He J, Shi X, Stefanovic-Racic M, Xu M, O'Doherty RM, Garcia-Ocana A, and Xie W (2012) Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes 61:1543-1551.
21. Gao J, He J, Zhai Y, Wada T, and Xie W (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284:25984-25992.
22. Gao J and Xie W (2010) Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab Dispos 38:2091-2095.
23. Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song WC, Cheng SY, and Xie W (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21:1781-1790. (Pubitemid 47173791)
24. Gong H, Jarzynka MJ, and Cole TJ, et al. (2008) Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 68:7386-7393.
25. Goodwin B, Jones SA, and Price RR, et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526.
26. Gustafsson JA (1997) Estrogen receptor beta - getting in on the action? Nat Med 3:493-494.
27. Harris HA (2007) Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 21:1-13.
28. Inagaki T, Choi M, and Moschetta A, et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217-225.
29. Jones ME, Boon WC, Proietto J, and Simpson ER (2006) Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 17:55-64.
30. Kamisuki S, Mao Q, and Abu-Elheiga L, et al. (2009) A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol 16:882-892.
31. Katsuma S, Hirasawa A, and Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386-390. (Pubitemid 40255465)
32. Katzenellenbogen JA (2011) The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands. J Med Chem 54:5271-5282.
33. Kawamata Y, Fujii R, and Hosoya M, et al. (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem 278:9435-9440. (Pubitemid 36800434)
34. Keitel V, Kubitz R, and Häussinger D (2008) Endocrine and paracrine role of bile acids. World J Gastroenterol 14:5620-5629.
35. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, and Gonzalez FJ (2007) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664-2672. (Pubitemid 350272851)
36. Kodama S, Koike C, Negishi M, and Yamamoto Y (2004) Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol 24:7931-7940. (Pubitemid 39167443)
37. Kodama S, Moore R, Yamamoto Y, and Negishi M (2007) Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem J 407:373-381. (Pubitemid 350058471)
38. Kong B, Wang L, Chiang JY, Zhang Y, Klaassen CD, and Guo GL (2012) Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56:1034-1043.
39. Konno Y, Negishi M, and Kodama S (2008) The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab Pharmacokinet 23:8-13.
40. Lahtela JT, Arranto AJ, and Sotaniemi EA (1985) Enzyme inducers improve insulin sensitivity in non-insulin-dependent diabetic subjects. Diabetes 34:911-916. (Pubitemid 15016555)
41. Li G, Thomas AM, Hart SN, Zhong X, Wu D, and Guo GL (2010) Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner. Mol Endocrinol 24:1404-1412.
42. Luna B and Feinglos MN (2001) Drug-induced hyperglycemia. JAMA 286:1945-1948. (Pubitemid 33010204)
43. Ma K, Saha PK, Chan L, and Moore DD (2006) Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116:1102-1109.
44. Malgarini RB and Pimpinella G (2011) Phentermine plus topiramate in the treatment of obesity. Lancet 378:125-126, author reply 126-127.
45. Markov GV and Laudet V (2011) Origin and evolution of the ligand-binding ability of nuclear receptors. Mol Cell Endocrinol 334:21-30.
46. Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, Nakamura T, Itadani H, and Tanaka K (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298:714-719. (Pubitemid 35356798)
47. Masuyama H and Hiramatsu Y (2012a) Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet-induced obese pregnant mice. Mol Cell Endocrinol 348:120-127.
48. Masuyama H and Hiramatsu Y (2012b) Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice. Am J Physiol Endocrinol Metab 303:E293-E300.
49. Matthews J and Gustafsson JA (2003) Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3:281-292.
50. Mauvais-Jarvis F (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 22:24-33.
51. Merk D and Schubert-Zsilavecz M (2012) Nuclear receptors as pharmaceutical targets: rise of FXR and rebirth of PPAR? Future Med Chem 4:587-588.
52. Müssig K, Staiger H, and Machicao F, et al. (2009) Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism 58:1809-1811.
53. Nguyen A and Bouscarel B (2008) Bile acids and signal transduction: role in glucose homeostasis. Cell Signal 20:2180-2197.
54. Palin SL, McTernan PG, Anderson LA, Sturdee DW, Barnett AH, and Kumar S (2003) 17Beta-estradiol and anti-estrogen ICI:compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism 52:383-388. (Pubitemid 36775326)
55. Prawitt J, Abdelkarim M, and Stroeve JH, et al. (2011) Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60:1861-1871.
56. Renga B, Mencarelli A, D'Amore C, Cipriani S, Baldelli F, Zampella A, Distrutti E, and Fiorucci S (2012) Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J 26:3021-3031.
57. Renga B, Mencarelli A, Vavassori P, Brancaleone V, and Fiorucci S (2010) The bile acid sensor FXR regulates insulin transcription and secretion. Biochim Biophys Acta 1802:363-372.
58. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, and Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630. (Pubitemid 40354745)
59. Ricquier D (2005) Respiration uncoupling and metabolism in the control of energy expenditure. Proc Nutr Soc 64:47-52.
60. Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ, and Greenberg AS (2009) Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 382:646-650.
61. Sato H, Genet C, Strehle A, Thomas C, Lobstein A, Wagner A, Mioskowski C, Auwerx J, and Saladin R (2007) Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 362:793-798. (Pubitemid 47398870)
62. Seale P, Bjork B, and Yang W, et al. (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454:961-967.
63. Shen H, Zhang Y, Ding H, Wang X, Chen L, Jiang H, and Shen X (2008) Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter. Cell Physiol Biochem 22:1-14.
64. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
65. Song WC, Moore R, McLachlan JA, and Negishi M (1995) Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant liver expression in obese and diabetogenic C57BL/KsJ-db/db mice. Endocrinology 136:2477-2484.
66. Sotaniemi EA and Karvonen I (1989) Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency. Diabetes Res 11:131-139. (Pubitemid 20043679)
67. Staels B and Kuipers F (2007) Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 67:1383-1392. (Pubitemid 47026388)
68. Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, Michael LF, and Burris TP (2005) Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 146:984-991. (Pubitemid 40289284)
69. Thanabalasundaram G, Arumalla N, Tailor HD, and Khan WS (2012) Regulation of differentiation of mesenchymal stem cells into musculoskeletal cells. Curr Stem Cell Res Ther 7:95-102.
70. Thomas AM, Hart SN, Kong B, Fang J, Zhong XB, and Guo GL (2010) Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology 51:1410-1419.
71. Thomas C, Gioiello A, and Noriega L, et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10:167-177.
72. Tian GX, Sun Y, Pang CJ, Tan AH, Gao Y, Zhang HY, Yang XB, Li ZX, and Mo ZN (2012) Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev 13:381-387.
73. Trauner M, Claudel T, Fickert P, Moustafa T, and Wagner M (2010) Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28:220-224.
74. van Dijk TH, Grefhorst A, Oosterveer MH, Bloks VW, Staels B, Reijngoud DJ, and Kuipers F (2009) An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/- mice. J Biol Chem 284:10315-10323.
75. Wada T, Ihunnah CA, Gao J, Chai X, Zeng S, Philips BJ, Rubin JP, Marra KG, and Xie W (2011) Estrogen sulfotransferase inhibits adipocyte differentiation. Mol Endocrinol 25:1612-1623.
76. Watanabe M, Houten SM, and Mataki C, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484-489. (Pubitemid 43152840)
77. Yabaluri N and Bashyam MD (2010) Hormonal regulation of gluconeogenic gene transcription in the liver. J Biosci 35:473-484.
78. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J, and Fukamizu A (2004) Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 279:23158-23165. (Pubitemid 38685621)
79. Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, Miller DD, Dalton JT, and Narayanan R (2010) Estrogen receptor-beta-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292-31303.
80. Zhai Y, Pai HV, Zhou J, Amico JA, Vollmer RR, and Xie W (2007) Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 21:138-147. (Pubitemid 46041695)
81. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, and Edwards PA (2006) Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci USA 103:1006-1011. (Pubitemid 43212212)
82. Zhou J, Febbraio M, and Wada T, et al. (2008) Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 134:556-567.
83. Zhou J, Zhai Y, Mu Y, Gong H, Uppal H, Toma D, Ren S, Evans RM, and Xie W (2006) A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem 281:15013-15020. (Pubitemid 43855205)